TrialJournal for immunotherapy of cancer2020

Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study.

Chiun-Sheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.